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Moringaceae, recorded high level of protease inhibitor activity after ammonium sulfate fraction-
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on isolation of the protease inhibitor. Among the different parts of M. oleifera tested, the crude
extract isolated from the mature leaves and seeds showed the highest level of inhibition against tryp-
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274 B. Bijina et al.proteases cathepsin B and papain which have more importance in pharmaceutical industry. The
protease inhibitor also showed complete inhibition of activities of the commercially available pro-
teases of Bacillus licheniformis and Aspergillus oryzae. However, inhibitory activities toward subtil-
isin, esperase, pronase E and proteinase K were negligible. Further, it was found that the protease
inhibitor could prevent proteolysis in a commercially valuable shrimpPenaeus monodon during stor-
age indicating the scope for its application as a seafood preservative. This is the ﬁrst report on iso-
lation of a protease inhibitor from M. oleifera.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Enzyme inhibitors have received increasing attention as useful
tools not only for the study of enzyme structures and reaction
mechanisms but also for potential utilization in pharmacology
(Cyran, 2002; Imada, 2005; Robert, 2005) and agriculture
(Ahn et al., 2004). Speciﬁc and selective protease inhibitors
are potentially powerful tools for inactivating target proteases
in the pathogenic process of human diseases such as emphy-
sema, arthritis, pancreatitis, thrombosis, high blood pressure,
muscular dystrophy, cancer and AIDS (Johnson and Pellecchi-
a, 2006). Protease inhibitors are one of the prime candidates
with highly proven inhibitory activity against insect pests
and are also known to improve the nutritional quality of food.
Insects that feed on plant material possess alkaline guts and
depend predominantly on serine proteases for digestion of
food materials and, therefore, protease inhibitors by virtue
of their anti-nutritional interaction can be employed effectively
as defense tools (Ryan, 1990). Microbial food spoilage is an
area of global concern as it has been estimated that as much
as 25% of all food produced is lost post-harvest owing to
microbial activity (Baird-Parker, 2003). The use of an ade-
quate amount of natural protease inhibitors is an effective
way to extend the shelf life of many types of seafood such as
salted ﬁsh products. This is due to the fact that the inhibitors
can retard several deteriorative processes like protein degrada-
tion caused by the action of endogenous and exogenous prote-
ases, during the food processing and preservation (Reppond
and Babbitt, 1993). Hence, protease inhibitors continue to at-
tract the attention of researchers due to their increasing use in
medicine and biotechnology (Dunaevsky et al., 1998).
A large number of protease inhibitors have been isolated
and identiﬁed from several plants (Tamir et al., 1996). Most
of the naturally occurring protease inhibitors were found in
plants and are well characterized. They belong to the group
of serine protease inhibitors which include trypsin (Richard-
son, 1991). However, protease inhibitor has not been so far re-
ported from Moringa oleifera, a panotropical multipurpose
tree with a high biomass yield and capable of tolerating unfa-
vorable environmental conditions (Foidl et al., 2001).M. oleif-
era grows well throughout the tropics and almost every part of
the plant is of value for food. The ﬂowers, leaves, and roots are
used in folk remedies for treatment of tumors and the seeds for
abdominal tumors. Bark regarded as antiscorbic and exudes a
reddish gum with properties of tragacanth is sometimes used
for diarrhea. Roots are bitter and act as a tonic to the body
and lungs. They are used as expectorant, mild diuretic, as stim-
ulant in paralytic afﬂictions, in epilepsy, and in hysteria (Hart-
well, 1971). In addition, several low molecular weight bioactive
compounds from Moringa seeds with bactericidal, fungicidal
and immunosuppressive activities (Mahajan and Mehta,2010) and some anti inﬂammatory agents (Caceres et al.,
1991; Cheenpracha et al., 2010) were also reported. Moreover
bioactive nitrile glycosides niaziridin and niazirin in the leaves,
pods and bark (Khanuja et al., 2005; Shanker et al., 2007) and
coagulant lectin as bio insecticide (Oliveira et al., 2010) were
also reported from this plant. In this communication, we re-
port the inhibitory activity of protease inhibitor isolated from
M. oleifera against therapeutically important and commer-
cially available proteases. Further their potential for use as
seafood preservative against proteolysis in Penaeus monodon
on storage was also evaluated.2. Materials and methods
2.1. Screening of plants for protease inhibitor
Plants, which are available from nearby areas around Cochin
University of Science and Technology campus, India, and
belonging to the families of Leguminosae, Malvaceae, Grami-
nae, Rutaceae and Guttiferae were used as source materials for
screening protease inhibitors. Different plant parts including
seeds, leaves, ﬂowers and bark were used for the study.
2.2. Extraction and recovery of protease inhibitor
Ideal solution that enables maximal extraction of the protease
inhibitor from the plant material was optimized by preparing
crude extract of leaves with different solutions. Fresh leaves
(25 g) from the mature plant was blended with 100 mL each
of sodium chloride 15% (w/v) (Wu and Whitaker, 1990), so-
dium hydroxide 0.2% (w/v), hydrochloric acid 0.05 M (Tawde,
1961), phosphate buffer 0.1 M (pH 7) (Wu and Whitaker,
1990) and distilled water.
Samples were washed thoroughly in distilled water and air-
dried. An extract was prepared in a 500 mL conical ﬂask by
homogenizing 25 g of plant materials in 100 mL of extractant
in an electrical blender. The homogenate was further mixed
thoroughly by incubating the contents at room temperature
(RT, 28 ± 2 C) in a rotary shaker for 30 min at 150 rpm.
The slurry was then ﬁltered through cheesecloth and the ﬁl-
trate was centrifuged (10,000 rpm, 15 min, 4 C) for removing
any cell debris that remains in the preparation (Pichare and
Kachole, 1996). The clear supernatant obtained represented
the crude extract, and was assayed for protease inhibitor activ-
ity and protein content.
2.3. Puriﬁcation of protease inhibitor
Protease inhibitor isolated from leaves of mature M. oleifera
(extracted with phosphate buffer, 0.1 M, pH 7) and puriﬁed
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tion with ion-exchange chromatography, gel ﬁltration by
Sephadex G75, and preparative PAGE (Bijina, 2006) was used.
2.4. Protease inhibitor assay
Protease inhibitor activity was assayed according to the meth-
od of Kunitz (1947) with slight modiﬁcations. One mL aliquot
of trypsin [EC 3.4.21.4, SRL, India(1000 units/mg)] (0.5 mg/
mL prepared in 0.1 M phosphate buffer pH 7) was pre-incu-
bated with 1 mL of a suitable dilution of the protease inhibitor
at 37 C for 15 min. To the above mixture 2 mL of 1% Ham-
merstein casein (SRL, India) (prepared in 0.1 M phosphate
buffer) was added and incubated at 37 C for 30 min. The reac-
tion was terminated by the addition of 2.5 mL of 0.44 M tri-
chloroacetic acid (TCA) solution. The reaction mixture was
transferred to a centrifuge tube and the precipitated protein
was removed by centrifugation at 10,000 rpm for 15 min (Sig-
ma, Germany). The absorbance of the clear supernatant was
measured at 280 nm in a UV–Visible spectrophotometer (Shi-
madzu, Japan) against appropriate blanks. The TCA soluble
peptide fractions of casein formed by the action of trypsin in
the presence and absence of the inhibitor were quantiﬁed by
comparing with tyrosine as standard. One unit of trypsin activ-
ity was deﬁned as the amount of enzyme that liberated 1 lg of
tyrosine per milliliter of the reaction mixture per minute under
the assay conditions. One unit of inhibitor activity was deﬁned
as the decrease by one unit of absorbance of TCA soluble case-
in hydrolysis product liberated by trypsin action measured at
280 nm per minute under the assay conditions. The protease
inhibitor activity was expressed in terms of percent inhibition.
Appropriate blanks for the enzyme, inhibitor, and the sub-
strate were also included in the assay along with the test.
2.5. Protein estimation
Protein content was determined according to the method of
Lowry et al. (1951) using Bovine Serum Albumin (BSA)
(SRL, India) as the standard and the concentration was ex-
pressed in milligram per milliliter (mg/mL).
2.6. Effect of protease inhibitor on proteases with therapeutic
importance
Effect of puriﬁed protease inhibitor on chymotrypsin
(EC.3.4.21.1, Product No. C3142, Sigma–Aldrich), thrombin
(EC.3.4.21.5, Product No. T7513, Sigma–Aldrich), Elastase
(EC.3.4.21.37, Product No. E8140, Sigma–Aldrich), cathep-
sin-B (EC.3.4.22.1, Product No. C6286, Sigma–Aldrich), pa-
pain (EC.3.4.22.2, Sisco Research Laboratories Pvt. Ltd.,
India), and collagenase (EC.3.4.24.3, Product No. C2674, Sig-
ma–Aldrich) activities were determined as described below.
Enzymes were assayed for their activities as per the proto-
cols detailed below and their inhibitions in the presence of
M. oleifera protease inhibitor were also assayed in the same
manner with the addition of the inhibitor (0.27 mg/mL) to
the respective reaction mixture and pre-incubation for 10 min
followed by assay of residual enzyme activity. Protease inhib-
itor unit is deﬁned as the amount of protease inhibitor that
inhibited one unit of respective enzyme activity. Protease
inhibitor activity of the respective enzyme is ﬁnally expressed
in terms of percent inhibition for comparative purposes.(a) Cathespin-B activity was assayed using 1.25-2.5 units/
mL of cathepsin B (Sigma–Aldrich) in cold deionised water
as described by Barrett (1981), using 20 mM N-succinyl-Ala-
Ala-Pro-Phe-p-nitroanilide in dimethyl sulphoxide as substrate
at 30 C for 5 min. One unit of enzyme will release one micro-
mole of p-nitro aniline per min from N-succinyl-Ala-Ala-Pro-
Phe-p-nitroanilide at pH 7 at 30 C. (b) Thrombin activity of
protease inhibitor was evaluated using 1 mg/mL of thrombin
(Sigma–Aldrich) in 0.1 M Tris–HCl buffer pH 7.5 and 1%
Hammerstein casein as substrate at 37 C for 30 min adopting
Kunitz caseinolytic method (Kunitz, 1947) (c) Elastase activity
was tested using 10 lg/mL of elastase (Sigma–Aldrich) solu-
tion according to Kunitz caseinolytic method (Ian, 2001;
Kunitz, 1947). (d) Collagenase activity was assayed using
1 mg/mL of collagenase (Sigma–Aldrich) and 1% gelatin as
substrate (Ian, 2001) at 37 C for 30 min. (e) Papain activity
was evaluated by Caseinolytic method (Murachi, 1970) using
papain (6 mg/mL) and 1% Hammerstein casein as substrate
at 37 C for 30 min. The reaction was interrupted by adding
1.5 mL of TCA (5% w/v). (f) Chymotrypsin activity was as-
sayed according to the modiﬁed method of Fritz et al.
(1966). Chymotrypsin from Bovine pancreas (Sigma–Aldrich)
was prepared by dissolving freeze dried pancreas in 0.001 M
HCl at a concentration of 1 mg/mL. Standard assay mixture
contained 0.05 M Tris–HCl buffer, pH 7.6, 20 mM peptide
substrate, N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, 0.27
mg/mL of inhibitor and chymotrypsin (10 lg/mL). One unit
of enzyme is deﬁned as the amount of enzyme that resulted
in the conversion of 1 lmol substrate per minute.
2.7. Effect of protease inhibitor on commercially available
proteases
Commercially available proteases-subtilisin (EC.3.4.21.14,
Product No. P5380, Sigma–Aldrich), esperase (EC.3.4.21.62,
Novozyme), pronase E (EC.3.4.24.31, Product No. P6911, Sig-
ma–Aldrich), proteinase K (EC.3.4.21.64, Product No. P2308,
Sigma–Aldrich), and that obtained from Bacillus sp. (Product
No. P3111, Sigma–Aldrich), Bacillus licheniformis (Product
No. P4860, Sigma–Aldrich), B. amyloliquefaciens (Product
No. P1236, Sigma–Aldrich) and Aspergillus oryzae (Product
No. P6110, Sigma–Aldrich) were evaluated for the effect of
the protease inhibitor on their activities. In addition, alkaline
protease isolated from Engyodontium album (BTMFS10) and
available in our laboratory was also evaluated. Protease assays
were carried out by adopting Kunitz caseinolytic method (Ku-
nitz, 1947) using Hammerstein casein as substrate. Respective
protease inhibitor activities were assayed in the same manner
with the addition of the inhibitor (0.27 mg/mL) to the respec-
tive reaction mixture and pre incubation for 10 min followed
by assay of residual enzyme activity. Protease inhibitor unit
is deﬁned as the amount of protease inhibitor that inhibited
one unit of respective enzyme activity.
2.8. Effect of protease inhibitor on proteolysis in shrimp P.
monodon during storage
P. monodon, known for its delicacy across the globe and with
commercial signiﬁcance, was selected for the study. The
‘‘peeled and undeveined’’ style of shrimp, which is the most
common type that is processed and exported, was used for
the experiments. Fresh shrimps obtained from ﬁsh landing site
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ported to the laboratory immediately, and processed. The
shrimps were peeled and the head removed aseptically to ob-
tain ‘‘peeled and undeveined’’ condition. The sample (10 g)
was taken in a sterile polyethylene bag, sealed, and kept at
each storage condition as the control. For the experiments,
three different sets of samples of the same weight were taken,
under the same conditions as that of the control, in sterile
polyethylene bags. They were added with 10 mL aliquots of
puriﬁed protease inhibitor at different concentrations (0.05,
0.1 and 0.2 mg/mL) and mixed well. The test samples thus pre-
pared were then incubated at RT (28 ± 2 C), 4 C and
20 C for 8, 24 and 168 h, respectively.
After incubation for speciﬁed periods, samples were drawn
and analyzed for microbial load (total viable counts) and pro-
tein content in the ﬂesh. Preparation of ﬂesh extract and esti-
mation of microbial load were performed using Flesh agar
plates (Chandrasekaran et al., 1985) incorporated with 1%
casein. Total protein of the samples was extracted using 5%
NaCl in 0.02 M sodium bicarbonate (Chandrasekaran, 1985)
and estimated as mentioned above.
3. Results and discussion
3.1. Screening of plants for protease inhibitor
Most of the natural protease inhibitors are proteinaceous in
nature and are located mainly in seeds, leaves and tubers,
which act as speciﬁc defense and regulatory proteins. Many re-
ports are available on the isolation, puriﬁcation and character-
ization of protease inhibitor from seeds of legume plants
(Ryan, 1990). Hence, few plants belonging to different families
of Leguminosae, Malvaceae, Rutaceae, Graminae and Mor-
ingaceae were screened for protease inhibitor. Results pre-
sented in Table 1 shows that the plants belonging to
Leguminosae family have maximum percent of inhibition to-Table 1 Screening of plants for protease inhibitor.
Serial No. Name of plants I
1 Adathoda vasica 7
2 Allium sepa
3 Azadirachta indica
4 Amaranthus viridis 5
5 Arachis hypogea 3
6 Beta vulgaris
7 Carica papaya 1
8 Cassia ﬁstula 3
9 Catharanthus roseus 4
10 Cicer arietinum 9
11 Cucurbita pepo 2
12 Dolichos biﬂorus 6
13 Hibiscus esculantus 1
14 Momordica charantia 8
15 Moringa oleifera 7
16 Ocimum sanctum 5
17 Oryza sativa 1
18 Phaseolus mungo 5
19 Pisum sativum 5
20 Phaseolus aureus 1
21 Solanum tuberosum 7
22 Triticum vulgare 4ward trypsin. Maximum inhibitory activity was shown by Cic-
er arietinum (98.21%) followed by Momordica charantia
(86.77%), M. oleifera (76.7%) and Adathoda vasica (76.12%).
3.2. Selection of potential source and isolation of protease
inhibitor from M. oleifera
In the present study, potential source for protease inhibitor
was selected based on the activity of the protease inhibitor.
The plants with more than 60% protease inhibitor activity
were further screened after partial puriﬁcation of the molecules
using ammonium sulfate precipitation in order to select the po-
tential proteinaceous protease inhibitor. Among the plants
evaluated, although M. oleifera showed maximal percent of
protease inhibition (92%) compared to others (Table 2), max-
imum speciﬁc activities of protease inhibitors were recorded
withM. charantia (1144) and Solanum tuberosum (192.36) com-
pared to M. oleifera (76.66). It was noted that among the ﬁve
plants selected, extracts ofM. oleifera, after ammonium sulfate
fractionation, recorded high level of protease inhibitor activity.
Hence, M. oleifera was selected for further studies.M. charan-
tia and S. tuberosum were not considered for further studies
since protease inhibitor from these plants were already well
characterized.
In spite of the fact that M. oleifera is known for containing
several low molecular weight bioactive constituents with phar-
maceutical and industrial applications (Kalogo et al., 2000)
protein inhibitors from the Moringaceae family was not yet
reported.
3.3. Distribution of protease inhibitor in different parts of M.
oleifera
From the data presented in Fig. 1, it is evident that among the
different parts of M. oleifera tested, the crude extract isolated
from the mature leaves and seeds showed highest level of inhi-nhibitory activity (%) Speciﬁc inhibitory activity
(units/mg protein)
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Figure 1 Distribution of protease inhibitor in different parts of
Moringa oleifera.
Table 2 Protease inhibitory activity of ammonium sulfate precipitated fractions of different plant extracts.
Serial No. Name of plants Saturation of (NH4)2SO4 (%) Protease inhibition (%) Speciﬁc activity (units/mg protein)
1 Adathoda vasica 30–60 31.16 103.86
2 Cicer areitinum 0–30 2.60 13.00
3 Momordica charantia 30–60 57.20 1144.00
4 Moringa oleifera 30–60 92.00 76.66
5 Solanum tuberosum 30–60 48.09 192.36
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Figure 2 Extraction of protease inhibitor using different
solvents.
Table 3 Speciﬁc activity of protease inhibitor extracted with
different extractants.
Serial No. Extraction medium Speciﬁc protease
inhibitor activity
(units/mg protein)
1 Sodium chloride (15%) 12.20 ± 0.05
2 Hydrochloric acid (0.05 M) 16.60 ± 0.04
3 Sodium hydroxide (0.2%) 11.60 ± 0.04
4 Distilled water 56.60 ± 0.23
5 Phosphate buﬀer (0.1 M) 30.20 ± 0.10
Protease inhibitor from Moringa oleifera with potential 277bition against trypsin. The crude extract prepared from leaves
showed maximum percent of inhibition (77%) followed by the
seed extract (63%). On evaluation of the distribution of prote-
ase inhibitor in different plant tissues of the matureM. oleifera
plant, it was observed that the mature leaves had maximum
percent of protease inhibition with maximum speciﬁc inhibitor
activity followed by the seeds when compared to ﬂowers, roots
and bark. Since leaves are the major tissues attacked by pest
and pathogens, the accumulation of this protease inhibitor is
maximum in leaves, compared to other parts, indicating a tis-
sue speciﬁc expression of these proteins. In winged bean plant,
western blot analysis of the expression of the protease inhibitor
in different tissues suggested that the expression of the prote-
ase inhibitor is tissue speciﬁc and species speciﬁc (Datta
et al., 2001). Hence, it may be presumed that leaves and seeds
of M. oleifera are rich sources of the protease inhibitor, which
is mostly directed toward serine proteases such as trypsin and
chymotrypsin.
3.4. Extraction of protease inhibitor from M. oleifera using
different solvents
Among the various extraction media evaluated for recovering
protease inhibitor from plant sources, the crude extract pre-
pared in phosphate buffer showed maximum protease inhibi-
tor activity (79%) followed by that prepared in distilled
water (68%) (Fig. 2). The inhibition of trypsin by the extract
prepared in sodium chloride and sodium hydroxide was very
less compared to that prepared in distilled water and phos-
phate buffer. Whereas, in terms of protein content in the crude
extract, phosphate buffer enabled maximal protein content
compared to other media, while distilled water extract con-tained very less protein although it showed high protease
inhibitor activity. The speciﬁc protease inhibitor activity ob-
tained for each extract is presented in Table 3.
The extraction medium has a major role in the complete
extraction of the protein from any desired source. Hence dif-
ferent solvents were used for extracting proteinaceous protease
inhibitors from the leaves. The protein concentration and the
protease inhibitor activity were maximal in the extract pre-
pared with phosphate buffer, which facilitated the complete re-
lease of proteins from the leaves into the solvent with
maximum inhibitor activity. The protease inhibitor activities
in the extracts prepared with sodium hydroxide and sodium
chloride were very less compared to that prepared in phos-
phate buffer, and distilled water. Even though extraction with
distilled water yielded maximum speciﬁc activity, phosphate
buffer was selected as the potent extraction medium for max-
278 B. Bijina et al.imal extraction of protease inhibitor from the leaves since loss
in inhibitor activity was negligible during further puriﬁcation.
In fact 0.1 M phosphate buffer (pH 7.6) was reported to be a
good extractant for the maximal extraction of proteins from
Cajanus cajan seeds with high amount of trypsin inhibitor
activity and protein concentration (Pichare and Kachole,
1996).
3.5. Effect of protease inhibitor on proteases with therapeutic
importance
From the results presented in Fig. 3 it was noted that the pro-
tease inhibitor obtained from M. oleifera could have high
afﬁnity toward the serine proteases thrombin, elastase fol-
lowed by chymotrypsin which is known for their pathological
and therapeutic importance. Cysteine proteases cathepsin B
and papain also recorded appreciable level of inhibition while
there was no signiﬁcant inhibition toward collagenase. Serine
protease inhibitors modulates protease activities and controls
a variety of the critical protease mediated processes like coag-
ulation, ﬁbrinolysis and tissue remodeling (Laskowski and
Kato, 1980), and also in the neurobiology of aging (Higgins
et al., 1990) and the development of cancer (Koivunen et al.,
1991). It is reported that a Kunitz type trypsin inhibitor from
Enterolobium contortisiliquum seeds strongly inhibited Bovine
trypsin and chymotrypsin and also some serine proteases in-
volved in the blood clotting cascade and the ﬁbrinogen prote-
olysis: human plasma kallikrein, Factor XIIa and plasmin
(Isabel et al., 1996). The high afﬁnity of the protease inhibitor
toward thrombin indicates scope for its use as an anticoagu-
lant agent.
It has been suggested that a cathepsin B-like protease, a
secretory form of lysosomal cathepsin B, present in some can-
cer exudates, is involved in the invasive process of cancer
pathology. Cysteine protease inhibitor present in the same
ﬂuid strongly inhibited the action of cathepsin B in the cancer
cells. Thus the inhibitor could play a protective role in the tu-
mor invasion (Keppler et al., 1985). Cathepsin B is known as
the major virulent proteases present in many protozoan dis-
eases like Leishmaniasis. An attractive target for new chemo-Proteases
Ch
ym
otr
yp
sin
Ela
sta
se
Th
rom
bin
Pa
pa
in
Ca
the
ps
in 
B
Co
lla
ge
na
se
 P
ro
te
as
e 
In
hi
bi
to
ry
 A
ct
iv
ity
 (%
)
0
20
40
60
80
100
120
Inhibitory Activity
Figure 3 Inhibitory activity of Moringa oleifera protease inhib-
itor toward pharmaceutically important proteases.therapy for Leishmaniasis is two cysteine proteases:
cathepsin B-like and cathepsin L-like, which are required for
parasitic growth and virulence (Mottram et al., 1998). It is re-
ported that peptide based cysteine protease inhibitors alter the
Golgi complex ultra structure and function in Trypanosoma
cruzi (Juan et al., 1998). In this context, the protease inhibitor
fromM. oleifera has promise as a possible drug against cathep-
sin B. It was reported that bitter gourd,M. charantia contains
both trypsin and elastase inhibitory protein (Hamato et al.,
1995). Plants are the richest source of antifungal proteins.
The potent antifungal protein isolated from broad bean is a
trypsin chymotrypsin inhibitor (Banks et al., 2002; Giudici
et al., 2000). From the results it is inferred that there is scope
for the use of this protease inhibitor fromM. oleifera as a drug
in pharmaceutical industries against elastase, thrombin, chy-
motrypsin and cathepsin B.
Based on the ability to inhibit proteases of insect digestive
tracts, protease inhibitors have been shown to have potential
usefulness as antifeedent agents. The majority of the protease
inhibitors exhibiting anti-feedent properties reported so far is
active against the neutral serine proteases such as trypsin
and chymotrypsin (Ryan, 1990). Studying plant defense re-
sponses and devising newer and ecofriendly strategies for plant
protection against pests and pathogens is today one of the
most dynamic areas of research in plant science. The insecti-
cidal effect of protease inhibitors, especially serine and cysteine
protease inhibitors, have been studied by direct incorporation
assays or by in vitro inhibition studies. They induced delayed
growth and development, reduced fecundity and sometimes in-
creased mortality (Annadana et al., 2002; Azzouz et al., 2005;
Oppert et al., 1993, 2003). It may be possible to develop the
M. oleifera protease inhibitor, by virtue of its activity against
trypsin and chymotrypsin, for the direct application as a bio-
control agent for the protection of plants against phytopatho-
genic fungi and to insects by encapsulation for surface
application or can be sprayed directly, once required feasibility
studies are conducted.
3.6. Effect of protease inhibitor on commercially available
proteases
The afﬁnity of M. oleifera protease inhibitor with different
industrially important proteases is also evaluated. From the re-
sults presented in Fig. 4, it was inferred that the protease inhib-
itor could completely inhibit the commercially available
proteases obtained from Bacillus sp., B. licheniformis, and A.
oryzae compared to reduced level of inhibition of protease of
B. amyloliquefaciens. Further 76% inhibition of activity in
the protease isolated from E. album was also noticed. In con-
trast the commercial proteases subtilisin, esperase, pronase
E, and proteinase K were not markedly inhibited by M. oleif-
era protease inhibitor. From the results it was noted that M.
oleifera protease inhibitor has high inhibitory activity against
bacterial proteases and protease of A. oryzae and E. album.
Currently, a large proportion of commercially available
proteases are derived from Bacillus strains (Abdel-Naby
et al., 1998; Mabrouk et al., 1999), although potential use of
fungal proteases is being increasingly realized (Joo et al.,
2001). These proteases have wide range of applications as addi-
tives in various industries such as detergents, leather process-
ing, and pharmaceuticals. Hence in the present study these
commercial enzymes were evaluated along with E. album, a
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Figure 5 Effect of protease inhibitor on the proteolysis in shrimp
Penaeus monodon during storage at different temperatures.
Protease inhibitor from Moringa oleifera with potential 279strain which was recognized to produce protease that has po-
tential for applications in detergent industry (Chellappan
et al., 2006). The results obtained for the inhibition studies
against these commercial enzymes indicate probable applica-
tion for the M. oleifera protease inhibitor in regulating their
activity.
Protease inhibitor (API-1) isolated from actinomycete was
reported to improve the thermal stability of protease of fungus
Conidiobolus macrosporous that has potential biotechnological
applications in both detergent and leather industries (Pandhare
et al., 2002). The alkaline protease was stable only up to 40 C
and lost its activity on increasing the temperature. It was found
that the binding of API-1 enhanced the stability of enzyme at
50 C up to 1 h (Pandhare et al., 2002). Thus thermal inactiva-
tion of detergent proteases can be prevented by binding of pro-
tease inhibitor. In the present study it was noted that the
protease inhibitor did not show any appreciable inhibitory
activity against detergent enzymes. This observation points
out to the probability that the protease inhibitor could be
developed toward use as stabilizer for imparting thermal sta-
bility of detergent enzymes.
3.7. Effect of protease inhibitor on protein degradation in shrimp
P. monodon during storage
The possible use of protease inhibitor toward controlling rapid
proteolysis and consequent spoilage in the shrimp, P. monodon
was evaluated by treating the peeled and undeveined samples
with protease inhibitor and incubation at different storage
temperatures. It was found that protease inhibitor highly inﬂu-
enced the microbial load and thus only 4 · 102 (cfu/mL) of to-
tal viable count (TVC) was recorded in the protease inhibitor
treated samples compared to 8 · 1010 of (cfu/mL) of TVC in
the control samples (data not shown). From the results pre-
sented in Fig. 5 it was noted that, at a dosage of 0.2 mg/mL,
there was 41% reduction in protein content of the untreated
sample at RT after 8 h of incubation when compared to the
respective control. But at reduced temperatures (4 and20 C) there was no considerable variation in the protein
contents of the untreated samples during storage when com-
pared to the initial values recorded at 0 h. Whereas, in protease
inhibitor treated samples there was no reduction in the level of
protein content indicating retardation in proteolysis at each
storage temperature studied. The impact of protease inhibitor
dosage on control of proteolysis was in a linear proportion
with the tested concentrations (data not shown) and the high-
est dosage tested (0.2 mg/mL) alone was presented in Fig. 5. It
is concluded that further studies with puriﬁed protease inhibi-
tor would facilitate appropriate selection of right dosage for
rapid control of proteolysis in sea food.
The protein hydrolysis in ﬁsh and shrimp muscle is gener-
ally an undesirable process and accounts for the loss of com-
modity during post harvest treatment. The presence of
proteases causes the softening of some ﬁsh muscle and also
causes gel weakening in ‘Surimi’. The protease-producing
organisms are responsible for the ﬁsh and shrimp muscle deg-
radation during preservation (Chandrasekaran, 1985; Chandr-
asekaran et al., 1987). At present, chemical preservatives and
antibiotics are used, but the use of enzyme inhibitor, which
is a part of the edible plant, could be the best alternative and
safe preservative. Many legume protease inhibitors have been
found to have inhibitory effects on the extracts of ﬁsh enzymes
(Soottawat et al., 1999). In this context, use of natural protease
inhibitor will be not only safe and effective for the control of
proteolysis and extension of shelf life but also environmental
friendly. The protease inhibitor isolated fromM. oleifera could
be used as a safe seafood preservative preventing proteolysis
and consequent spoilage for proteinaceous sea food.
4. Conclusions
Based on the results obtained for the studies conducted with
the M. oleifera protease inhibitor on various proteases, it is
concluded that M. oleifera protease inhibitor has immense po-
tential for the development of suitable drugs in pharmaceutical
industries against thrombin, elastase, chymotrypsin, trypsin,
cathepsin, and papain. Further this protein protease inhibitor
could become an ideal candidate for use as a seafood
280 B. Bijina et al.preservative against proteolysis, in various biotechnological
applications especially in food industry, and also as a biocon-
trol defense protein for the protection of plants against pest
and pathogen infestations.
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